A lot goes into choosing a medication for a patient. There are best practices, consideration of a patient's medical history and insurance coverage. And there's also cost.
RxRevu allows doctors to take all those factors and more into consideration through its prescription decision-support platform, RxCheck, which helps clinicians choose which drug to give a patient based on that patient's personal health information, cost and other guidelines.
"RxCheck brings together two critical pieces of information: clinical information and insurance information," said Carm Huntress, CEO of RxRevu, the Denver company he founded in 2013. Information tailored to each patient can reduce clinical variability. "We're helping providers make more informed decisions," Huntress said. "This is driving safety and efficacy."
It's also driving patient satisfaction, he said. "Patients aren't getting to the pharmacy anymore and finding that the medication isn't covered or there's a prior authorization needed."
This kind of decision support is essential, Huntress said, especially as health systems move into value-based payment models. Not only does it help improve outcomes by getting patients on the right medications at the point of care, but it also yields insight into providers' prescribing habits. Clinical administrators can see the prescribing patterns of their providers and help them improve if need be.
RxRevu has raised $5 million to date. The company's software is in use at five health systems across the country. Some of those deployments, for primary-care providers, cover every drug that could be prescribed in a primary-care setting. Others are focused on drugs for specific conditions.